{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:30:11Z","timestamp":1787567411323,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57326-3","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:10:45Z","timestamp":1787562645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical characteristics of dermatophytosis in rheumatoid arthritis according to DMARD therapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-7885","authenticated-orcid":false,"given":"Muhammet","family":"Limon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-5373","authenticated-orcid":false,"given":"Nurdan","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-6759","authenticated-orcid":false,"given":"Umit","family":"T\u00fcrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6123-1660","authenticated-orcid":false,"given":"Fatih","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5261-9379","authenticated-orcid":false,"given":"Ayse Nur Sar\u0131bas","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"57326_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1517\/14712598.8.4.491","volume":"8","author":"E Ducharme","year":"2008","unstructured":"Ducharme, E., Weinberg, J. M. & Etanercept Expert Opin. Biol. Ther. 8, 491\u2013502 (2008).","journal-title":"Expert Opin. Biol. Ther."},{"key":"57326_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1517\/14740338.4.4.637","volume":"4","author":"N Scheinfeld","year":"2005","unstructured":"Scheinfeld, N. Adalimumab: a review of side effects. Expert Opin. Drug Saf. 4, 637\u2013641 (2005).","journal-title":"Expert Opin. Drug Saf."},{"key":"57326_CR3","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2147\/DDDT.S200147","volume":"13","author":"S Subedi","year":"2019","unstructured":"Subedi, S., Gong, Y., Chen, Y. & Shi, Y. Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events. Drug Des. Devel Ther. 13, 2491\u20132502 (2019).","journal-title":"Drug Des. Devel Ther."},{"key":"57326_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","volume":"51","author":"B Havlickova","year":"2008","unstructured":"Havlickova, B., Czaika, V. A. & Friedrich, M. Epidemiological trends in skin mycoses worldwide. Mycoses 51, 2\u201315 (2008).","journal-title":"Mycoses"},{"key":"57326_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11046-008-9100-9","volume":"166","author":"C Seebacher","year":"2008","unstructured":"Seebacher, C., Bouchara, J. P. & Mignon, B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 166, 335\u2013352 (2008).","journal-title":"Mycopathologia"},{"key":"57326_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clindermatol.2009.12.005","volume":"28","author":"M Ameen","year":"2010","unstructured":"Ameen, M. Epidemiology of superficial fungal infections. Clin. Dermatol. 28, 197\u2013201 (2010).","journal-title":"Clin. Dermatol."},{"key":"57326_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0733-8635(05)70322-3","volume":"14","author":"GD Masri-Fridling","year":"1996","unstructured":"Masri-Fridling, G. D. Dermatophytosis of the feet. Dermatol. Clin. 14, 33\u201340 (1996).","journal-title":"Dermatol. Clin."},{"key":"57326_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00296-002-0238-3","volume":"23","author":"A Bicer","year":"2003","unstructured":"Bicer, A. et al. Prevalence of dermatophytosis in patients with rheumatoid arthritis. Rheumatol. Int. 23, 37\u201340 (2003).","journal-title":"Rheumatol. Int."},{"key":"57326_CR9","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1111\/j.1439-0507.2010.01930.x","volume":"54","author":"F Bardazzi","year":"2011","unstructured":"Bardazzi, F., Balestri, R., Rech, G., Antonucci, A. & Patrizi, A. Dermatophytosis during anti-TNF-\u03b1 monoclonal antibody therapy. Mycoses 54, e199\u2013e201 (2011).","journal-title":"Mycoses"},{"key":"57326_CR10","first-page":"274","volume":"83","author":"BM Ribotsky","year":"2009","unstructured":"Ribotsky, B. M. Sertaconazole nitrate cream 2% for the treatment of tinea pedis. Cutis 83, 274\u2013277 (2009).","journal-title":"Cutis"},{"key":"57326_CR11","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1038\/s41598-022-17744-5","volume":"12","author":"JH Son","year":"2022","unstructured":"Son, J. H. et al. Risk factors of dermatophytosis among Korean adults. Sci. Rep. 12, 13444 (2022).","journal-title":"Sci. Rep."},{"key":"57326_CR12","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay, J. & Upchurch, K. S. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51, vi5\u2013vi9 (2012).","journal-title":"Rheumatology"},{"key":"57326_CR13","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad, N. et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status. Lancet 401, 1878\u20131890 (2023).","journal-title":"Lancet"},{"key":"57326_CR14","first-page":"281","volume":"15","author":"C Lindhaus","year":"2017","unstructured":"Lindhaus, C., Tittelbach, J. & Elsner, P. Nebenwirkungen von TNF-alpha-Inhibitoren am Hautorgan. J. Dtsch. Dermatol. Ges. 15, 281\u2013288 (2017).","journal-title":"J. Dtsch. Dermatol. Ges"},{"key":"57326_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1023\/B:MYCO.0000030447.78197.fb","volume":"157","author":"S Metintas","year":"2004","unstructured":"Metintas, S. et al. Frequency and risk factors of dermatophytosis in students living in rural areas in Eskisehir. Mycopathologia 157, 379\u2013382 (2004).","journal-title":"Mycopathologia"},{"key":"57326_CR16","first-page":"1","volume":"55","author":"O Oninla","year":"2012","unstructured":"Oninla, O. & Oninla, S. Superficial mycoses in relation to age and gender. Mycoses 55, 1\u20135 (2012).","journal-title":"Mycoses"},{"key":"57326_CR17","first-page":"1","volume":"31","author":"AP Schoeler","year":"2010","unstructured":"Schoeler, A. P. et al. Preval\u00eancia de dermat\u00f3fitos na rotina de micologia em hospital particular de m\u00e9dio porte. Rev. Cienc. Farm. Basica Apl. 31, 1\u20135 (2010).","journal-title":"Rev. Cienc. Farm. Basica Apl"},{"key":"57326_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1590\/S0365-05962006000300005","volume":"81","author":"JAA Oliveira","year":"2006","unstructured":"Oliveira, J. A. A., Barros, J. A., Cortez, A. C. A. & Oliveira, J. R. S. L. Superficial mycoses in the city of Manaus. Bras. Dermatol. 81, 238\u2013243 (2006).","journal-title":"Bras. Dermatol."},{"key":"57326_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/abd1806-4841.20142569","volume":"89","author":"CAA Pires","year":"2014","unstructured":"Pires, C. A. A. et al. Clinical, epidemiological, and therapeutic profile of dermatophytosis. Bras. Dermatol. 89, 259\u2013264 (2014).","journal-title":"Bras. Dermatol."},{"key":"57326_CR20","first-page":"347","volume":"37","author":"C Croia","year":"2019","unstructured":"Croia, C. et al. Pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 37, 347\u2013357 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"57326_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1248\/bpb.b17-00982","volume":"41","author":"M Takeno","year":"2018","unstructured":"Takeno, M. et al. 5-Hydroxy-2-methylpyridine isolated from cigarette smoke condensate aggravates collagen-induced arthritis in mice. Biol. Pharm. Bull. 41, 877\u2013884 (2018).","journal-title":"Biol. Pharm. Bull."},{"key":"57326_CR22","doi-asserted-by":"publisher","first-page":"e2014017","DOI":"10.4178\/epih\/e2014017","volume":"36","author":"HJ Yoon","year":"2014","unstructured":"Yoon, H. J., Choi, H. Y., Kim, Y. K., Song, Y. J. & Ki, M. Prevalence of fungal infections using national health insurance data. Epidemiol. Health. 36, e2014017 (2014).","journal-title":"Epidemiol. Health"},{"key":"57326_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","volume":"133","author":"BE Elewski","year":"1997","unstructured":"Elewski, B. E. & Charif, M. A. Prevalence of onychomycosis in patients attending a dermatology clinic. Arch. Dermatol. 133, 1172\u20131173 (1997).","journal-title":"Arch. Dermatol."},{"key":"57326_CR24","first-page":"2","volume":"32","author":"RK Scher","year":"2013","unstructured":"Scher, R. K., Rich, P., Pariser, D. & Elewski, B. Epidemiology, etiology and pathophysiology of onychomycosis. J. Am. Acad. Dermatol. 32, 2\u20134 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"57326_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1365-4362.1999.00015.x","volume":"38","author":"E Haneke","year":"1999","unstructured":"Haneke, E. & Roseeuw, D. The scope of onychomycosis: epidemiology and clinical features. Int. J. Dermatol. 38, 7\u201312 (1999).","journal-title":"Int. J. Dermatol."},{"key":"57326_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-4632.2008.03606.x","volume":"47","author":"SJ Chang","year":"2008","unstructured":"Chang, S. J. et al. Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus. Int. J. Dermatol. 47, 467\u2013472 (2008).","journal-title":"Int. J. Dermatol."},{"key":"57326_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911\u2013919 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57326_CR28","doi-asserted-by":"crossref","unstructured":"Coppack, S. W. Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc. 60, 349\u2013356 (2001).","DOI":"10.1079\/PNS2001110"},{"key":"57326_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1473-3099(06)70523-0","volume":"6","author":"ME Falagas","year":"2006","unstructured":"Falagas, M. E. & Kompoti, M. Obesity and infection. Lancet Infect. Dis. 6, 438\u2013446 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"57326_CR30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/acr.24042","volume":"71","author":"BR England","year":"2019","unstructured":"England, B. R. et al. 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res. 71, 1540\u20131555 (2019).","journal-title":"Arthritis Care Res."},{"key":"57326_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1521-6942(03)00041-X","volume":"17","author":"TR Mikuls","year":"2003","unstructured":"Mikuls, T. R. Co-morbidity in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 17, 729\u2013752 (2003).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"57326_CR32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/rheumatology\/kep101","volume":"48","author":"A McLean-Tooke","year":"2009","unstructured":"McLean-Tooke, A., Aldridge, C., Waugh, S., Spickett, G. P. & Kay, L. Methotrexate, rheumatoid arthritis and infection risk\u2014what is the evidence? Rheumatology 48, 867\u2013871 (2009).","journal-title":"Rheumatology"},{"key":"57326_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.2010.128637","volume":"70","author":"K Au","year":"2011","unstructured":"Au, K. et al. High disease activity is associated with an increased risk of infection in rheumatoid arthritis. Ann. Rheum. Dis. 70, 785\u2013791 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"57326_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/03009749409102137","volume":"23","author":"A Stenger","year":"1994","unstructured":"Stenger, A., Houtman, P., Bruyn, G., Eggink, H. & Pasma, H. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment. Scand. J. Rheumatol. 23, 51\u201353 (1994).","journal-title":"Scand. J. Rheumatol."},{"key":"57326_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archderm.1992.01680110101015","volume":"128","author":"LA Witty","year":"1992","unstructured":"Witty, L. A., Steiner, F., Curfman, M., Webb, D. & Wheat, L. J. Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis. Arch. Dermatol. 128, 91\u201393 (1992).","journal-title":"Arch. Dermatol."},{"key":"57326_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1439-0507.2012.02170.x","volume":"55","author":"R Balestri","year":"2012","unstructured":"Balestri, R. et al. Pityriasis versicolor during anti-TNF-\u03b1 monoclonal antibody therapy: therapeutic considerations. Mycoses 55, 444\u2013446 (2012).","journal-title":"Mycoses"},{"key":"57326_CR37","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1097\/MIB.0b013e31828f1fba","volume":"19","author":"ME Ordonez","year":"2013","unstructured":"Ordonez, M. E., Farraye, F. A. & Di Palma, J. A. Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy. Inflamm. Bowel Dis. 19, 2490\u20132500 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"57326_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.25251\/skin.5.4.11","volume":"5","author":"S Otto-Meyer","year":"2021","unstructured":"Otto-Meyer, S. & Nahi, S. Blastomycosis infection in the setting of immunosuppression with concurrent methotrexate and adalimumab. SKIN. J. Cutan. Med. 5, 406\u2013409 (2021).","journal-title":"SKIN. J. Cutan. Med."},{"key":"57326_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/648724","volume":"50","author":"CA Hage","year":"2010","unstructured":"Hage, C. A. et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin. Infect. Dis. 50, 85\u201392 (2010).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57326-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:10:48Z","timestamp":1787562648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57326"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57326-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by Mersin University Faculty of Medicine Clinical Research Ethics Committee (Session No. 2024\/882, Decision No: 17). All patients were informed for the investigation, and the study was performed in accordance with the principles of the Declaration of Helsinki. All participants provided written informed con sent to be included in the study and their aggregated data to be used for scientific publications.","order":2,"name":"Ethics","label":"Ethics and consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26491"}}